Follow-The-Filings

ACXP Acurx Pharmaceuticals

Acurx Pharmaceuticals earnings company data as of 7:43 AM ET 8/20

  • 0 of 1 EPS beats

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -0.44 -0.53 Miss
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q 10-Q
424B3 424B3
424B3 424B3
10-Q 10-Q
S-1 FORM S-1
S-1 FORM S-1
424B5 424B5
8-K 1.01,3.02,8.01,9.01
10-K 10-K
8-K 5.02,8.01,9.01
424B3 424B3
S-1 S-1
10-Q 10-Q
424B3 424B3
S-1 FORM S-1
8-K 5.03,9.01
8-K 5.07
10-Q 10-Q
DEFA14A DEFA14A
8-K 3.03,5.03,8.01,9.01
8-K 5.07
S-1 FORM S-1
8-K 1.01,3.02,8.01,9.01
DEFA14A DEFA14A
424B3 424B3

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 of 8 shown

Filed Form Detail Links
4 OWNERSHIP DOCUMENT
4 OWNERSHIP DOCUMENT
4 OWNERSHIP DOCUMENT
4 OWNERSHIP DOCUMENT
4 OWNERSHIP DOCUMENT

3 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice